Mock Inspection Consulting Project for a Clinical-Stage Biopharmaceutical Company
As the GCP landscape continually evolves, sponsors are encouraged to pursue innovative approaches. Mock Inspections are a critical tool to ensure inspection readiness and a quality control step to confirm that the innovative approaches are being implemented in a regulatorily compliant way. Inspection Readiness needs to keep pace with this philosophy and to be proactive, risk-based, and agile.
A mid-sized clinical-stage biopharmaceutical company intended to submit a Biologics License Application (BLA) mid-year in 2019. The company requested that The Avoca Group conduct a 4-day on-site Mock Inspection with a regulatory agency focus on the FDA.
Because the company was a Member of the Avoca Quality Consortium® (AQC), Avoca’s project team leveraged AQC leading practices, where applicable.
To download the White Paper, complete the form.